Methods and devices to assist pulmonary decompression
First Claim
1. A method for treating a lung of a patient through an artificial aperture through a chest wall of the patient, wherein the artificial aperture passes through the chest wall, through a parietal membrane and through a visceral membrane into alveolar tissue of the lung, and wherein the visceral membrane is sealed to the parietal membrane around the artificial aperture, where the artificial aperture passes through the parietal membrane and the visceral membrane, to prevent pneumothorax, wherein the method comprises:
- positioning an internal section which includes a first end, a second end, and a channel extending from the second end to the first ends, through the artificial aperture into alveolar tissue of the lung outside of the bronchi of the patient, such that the air present in the alveolar tissue of the lung of the patient may pass into the channel;
securing a housing, which is connected to the first end of the internal section, to the outside of the chest of the patient; and
operating a power-operated ventilation device within the housing to promote flow of air from the alveolar tissue of the lung through the channel and expel the air outside of the patient.
5 Assignments
0 Petitions
Accused Products
Abstract
A long term oxygen therapy system having an oxygen supply directly linked with a patient'"'"'s lung or lungs may be utilized to more efficiently treat hypoxia caused by chronic obstructive pulmonary disease such as emphysema and chronic bronchitis. The system includes an oxygen source, one or more valves and fluid carrying conduits. The fluid carrying conduits link the oxygen source to diseased sites within the patient'"'"'s lungs. A collateral ventilation bypass trap system directly linked with a patient'"'"'s lung or lungs may be utilized to increase the expiratory flow from the diseased lung or lungs, thereby treating another aspect of chronic obstructive pulmonary disease. The system includes a trap, a filter/one-way valve and an air carrying conduit. In various embodiments, the system may be intrathoracic, extrathoracic or a combination thereof. A pulmonary decompression device may also be utilized to remove trapped air in the lung or lungs, thereby reducing the volume of diseased lung tissue. In order for the system to be effective, an airtight seal between the parietal and visceral pleurae is required. Chemical pleurodesis is utilized for creating the seal.
365 Citations
20 Claims
-
1. A method for treating a lung of a patient through an artificial aperture through a chest wall of the patient, wherein the artificial aperture passes through the chest wall, through a parietal membrane and through a visceral membrane into alveolar tissue of the lung, and wherein the visceral membrane is sealed to the parietal membrane around the artificial aperture, where the artificial aperture passes through the parietal membrane and the visceral membrane, to prevent pneumothorax, wherein the method comprises:
-
positioning an internal section which includes a first end, a second end, and a channel extending from the second end to the first ends, through the artificial aperture into alveolar tissue of the lung outside of the bronchi of the patient, such that the air present in the alveolar tissue of the lung of the patient may pass into the channel; securing a housing, which is connected to the first end of the internal section, to the outside of the chest of the patient; and operating a power-operated ventilation device within the housing to promote flow of air from the alveolar tissue of the lung through the channel and expel the air outside of the patient. - View Dependent Claims (2, 3, 4, 5, 6, 7)
-
-
8. A method for treating a lung of a patient the method comprising:
-
(a) identifying an implantation location in a lung of the patient; (b) introducing a first end of a device having a channel, through a chest wall of the patient and into alveolar tissue of the lung outside of the bronchi by inserting the first end of the device through a visceral membrane and through a parietal membrane, within a localized region where the visceral membrane is sealed to the parietal membrane, such that air within the alveolar tissue of the lung at the implantation location can enter the channel of the device; and (c) coupling the channel to a power-operated decompression device located on the chest of the patient whereby the power-operated decompression device is configured to create a pressure differential to promote movement of air from the alveolar tissue of the lung through the channel. - View Dependent Claims (9, 10, 11, 12, 13, 14)
-
-
15. A method which removes air from a lung of a patient through an artificial aperture in a chest of the patient, wherein a seal has been formed between a parietal membrane and visceral membrane in a localized region, and wherein the artificial aperture penetrates from outside the chest into the alveolar tissue of the lung through the parietal membrane and through the visceral membrane within the localized region, such that the parietal membrane is sealed to the visceral membrane around the artificial aperture to prevent pneumothorax, wherein the method comprises:
-
positioning a conduit through the artificial aperture in the chest of the patient into a lung, wherein the conduit includes a first end, a second end and a channel extending from the second end to the first end such that the air present in the alveolar tissue of the lung of the patient may pass into the channel; securing an external housing coupled to the first end of the conduit to the chest of the patient; and operating a power-operated device within the external housing to draw air from the alveolar tissue of the lung through the channel and expel the air external to the patient; and using a portable power supply to provide power to the power-operated device. - View Dependent Claims (16, 17, 18, 19, 20)
-
Specification